Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001067044 | SCV001232074 | pathogenic | not provided | 2021-02-24 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 6 of the SET gene. It does not directly change the encoded amino acid sequence of the SET protein. It affects a nucleotide within the consensus splice site of the intron. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of SET-related intellectual disability (Invitae). In at least one individual the variant was observed to be de novo. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. |
Undiagnosed Diseases Network, |
RCV002252311 | SCV002523177 | pathogenic | Intellectual disability, autosomal dominant 58 | 2021-02-25 | criteria provided, single submitter | clinical testing |